Intellia Therapeutics Inc (NTLA)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

40 ERIE STREET CAMBRIDGE, MA 02139

Intellia Therapeutics, Inc. operates as a biotechnology company. The Company focuses on the research and clinical development of gene editing therapies for patients with genetically-based diseases.

Data as of 2021-04-11 07:53:33 -0400
Market Cap4.784 Billion Shares Outstanding67.726 Million Avg 30-day Volume1.459 Million
P/E Ratio-35.64146 Dividend Yield EPS-2.4
Price/Sales82.49 Debt to Equity1.28 EBITDA-130.272 Million
Price to Book Value9.08 Forward PE-24.99 Enterprise Value4.187 Billion
Total Cash597.371 Million Current Debt64.254 Million Gross Profit57.994 Million
BETA1.83561 52-week High/Low92.0 / 12.19 Next Earnings Date2021-05-06 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from NTLA instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 3 2 50.0% 0 (0.0%) 0 (0.0%)
Funds Holding: 230 161 42.86% 67 (4.03%) 43 (2.68%) 55.81%
13F shares: 60.035 Million 56.472 Million 6.31% 25.916 Million 24.901 Million 4.08%
% Ownership 92.9414 95.5839 -2.76% 40.1205 42.1471 -4.81%
New Positions: 87 25 248.0% 27 7 285.71%
Increased Positions 66 67 -1.49% 15 18 -16.67%
Closed Positions 16 24 -33.33% 3 9 -66.67%
Reduced Positions 49 33 48.48% 19 9 111.11%
Total Calls 290.694 Thousand 163.502 Thousand 77.79% 70.2 Thousand 65.9 Thousand 6.53%
Total Puts 1.434 Million 95.908 Thousand 1395.47% 678.4 Thousand 47.9 Thousand 1316.28%
PUT/CALL Ratio 4.93 0.59 735.59% 9.66 0.73 1223.29%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding NTLA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NTLA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

598.9 Thousand total shares from 28 transactions

Exercise Derivative Conversion (M)

175.5 Thousand total shares from 7 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

KERESTY GEORGIA

  • Director
12,710 2021-04-09 2

FORMELA JEAN FRANCOIS

  • Director
1,112,576 2021-04-05 3

DORSA CAROLINE

  • Director
14,498 2021-04-05 2

LEONARD JOHN M PRESIDENT AND CEO

  • Officer
  • Director
1,025,742 2021-04-01 14

RIVERA JOSE E EVP, GENERAL COUNSEL

  • Officer
430,714 2021-04-01 14

SCHIERMEIER ANDREW EVP, CHIEF OPERATING OFFICER

  • Officer
91,875 2021-03-03 3

GODDARD GLENN EVP, CHIEF FINANCIAL OFFICER

  • Officer
85,750 2021-03-03 1

SEPP-LORENZINO LAURA EVP, CHIEF SCIENTIFIC OFFICER

  • Officer
98,000 2021-03-03 1

LEBWOHL DAVID EVP, CHIEF MEDICAL OFFICER

  • Officer
89,250 2021-03-03 3

COHEN FRED E

  • Director
30,000 2021-01-20 2

KARSEN PERRY A

  • Director
5,000 2020-12-17 2

CROWLEY JOHN F

  • Director
0 2020-10-02 2

VERWIEL FRANK

  • Director
0 2020-06-18 1

GOODMAN JESSE

  • Director
0 2020-06-18 1

NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.

NOVARTIS AG

  • 10% Owner
4,352,295 2018-12-31 0

HAYES JOHN T. SEE REMARKS

  • Officer
0 2018-08-03 0

BELL GRAEME EVP, CHIEF FINANCIAL OFFICER

  • Officer
21,400 2018-03-28 0

CARIBOU BIOSCIENCES, INC.

No longer subject to file 2018-01-29 0

BERMINGHAM NESSAN PRESIDENT & CEO

  • Officer
  • Director
0 2017-12-12 0

SLAOUI MONCEF

  • Director
0 2017-07-25 0

ATLAS VENTURE FUND IX, L.P.

ATLAS VENTURE ASSOCIATES IX, L.P.

ATLAS VENTURE ASSOCIATES IX, LLC

  • 10% Owner
3,579,788 2017-07-07 0

GORDON CARL L

  • Director
0 2017-05-18 0

ATLAS VENTURE ASSOCIATES IX, L.P.

ATLAS VENTURE ASSOCIATES IX, LLC

  • 10% Owner
3,729,788 2017-03-09 0

MORRISSEY DAVID V SVP, PLATFORM & DELIVERY TECH

  • Officer
0 2017-01-06 0

BARNES THOMAS M. SVP, R&D EXTELLIA

  • Officer
0 2017-01-06 0

HEIFNER NICOLE SVP, ACCOUNTING

  • Officer
0 2017-01-06 0

BAKER BROS. ADVISORS LP

BAKER FELIX

BAKER JULIAN

BAKER BROS. ADVISORS (GP) LLC

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
No longer subject to file 2016-05-11 0

TEMASEK HOLDINGS (PRIVATE) LTD

FULLERTON MANAGEMENT PTE LTD

TEMASEK LIFE SCIENCES PRIVATE LTD

TLS BETA PTE. LTD.

  • 10% Owner
No longer subject to file 2016-05-11 0

ORBIMED ADVISORS LLC

ORBIMED CAPITAL GP V LLC

ORBIMED GLOBAL HEALTHCARE GP LLC

ISALY SAMUEL D

  • Director
2,662,180 2016-05-11 0

CARIBOU THERAPEUTICS HOLDCO, LLC

CARIBOU BIOSCIENCES, INC.

  • 10% Owner
5,593,846 2016-05-11 0

HAURWITZ RACHEL E.

  • Director
  • 10% Owner
5,593,846 2016-05-11 0

FORESITE CAPITAL MANAGEMENT III, LLC

FORESITE CAPITAL FUND III, L.P.

TANANBAUM JAMES B.

  • 10% Owner
0 2016-05-05 0

SRIVASTAVA SAPNA CHIEF FINANCIAL & STATEGY OFFR

  • Officer
159,031 2016-05-05 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

KERESTY GEORGIA - Director

2021-04-13 16:37:14 -0400 2021-04-09 A 7,755 a 7,755 direct

KERESTY GEORGIA - Director

2021-04-13 16:37:14 -0400 2021-04-09 A 4,955 a 4,955 direct

DORSA CAROLINE - Director

2021-04-06 18:09:59 -0400 2021-04-05 M 7,500 d 9,088 direct

DORSA CAROLINE - Director

2021-04-06 18:09:59 -0400 2021-04-05 S 2,014 $81.49 d 10,896 direct yes 2.7993 2.7993 2 0.0 1

DORSA CAROLINE - Director

2021-04-06 18:09:59 -0400 2021-04-05 S 800 $82.99 d 5,410 direct yes 2.7993 2.7993 2 0.0 1

DORSA CAROLINE - Director

2021-04-06 18:09:59 -0400 2021-04-05 M 7,500 $6.40 a 12,910 direct 2.7993 2.7993 2 0.0 1

FORMELA JEAN FRANCOIS - Director see footnote

2021-04-07 14:14:37 -0400 2021-04-05 S 800 $84.98 d 1,112,576 indirect 2.7993 2.7993 2 0.0 1

DORSA CAROLINE - Director

2021-04-06 18:09:59 -0400 2021-04-05 S 4,686 $82.35 d 6,210 direct yes 2.7993 2.7993 2 0.0 1

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 S 1,965 $80.85 d 176,112 direct yes -0.7603 -14.7326 0.0 1 -14.7326 6

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 S 1,049 $83.98 d 145,199 direct yes -0.7603 -14.7326 0.0 1 -14.7326 6

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 S 700 $80.73 d 149,843 direct yes -0.7603 -14.7326 0.0 1 -14.7326 6

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 S 1,724 $83.72 d 141,506 direct yes -0.7603 -14.7326 0.0 1 -14.7326 6

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 S 1,256 $80.82 d 150,776 direct yes -0.7603 -14.7326 0.0 1 -14.7326 6

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 S 3,234 $83.91 d 132,099 direct yes -0.7603 -14.7326 0.0 1 -14.7326 6

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 S 2,010 $80.79 d 146,832 direct yes -0.7603 -14.7326 0.0 1 -14.7326 6

LEONARD JOHN M - Director - Officer PRESIDENT AND CEO

2021-04-02 20:46:42 -0400 2021-04-01 M 45,000 d 155,000 direct

LEONARD JOHN M - Director - Officer PRESIDENT AND CEO

2021-04-02 20:46:42 -0400 2021-04-01 S 24,314 $84.00 d 681,222 direct yes -0.7603 -14.7326 0.0 1 -14.7326 6

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 M 10,000 d 51,000 direct

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 S 124 $85.76 d 162,388 direct yes -0.7603 -14.7326 0.0 1 -14.7326 6

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 S 3,361 $82.77 d 165,983 direct yes -0.7603 -14.7326 0.0 1 -14.7326 6

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 M 33,001 $6.83 a 178,077 direct -0.7603 -14.7326 0.0 1 -14.7326 6

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 S 951 $82.87 d 146,248 direct yes -0.7603 -14.7326 0.0 1 -14.7326 6

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 M 10,000 $14.58 a 150,543 direct -0.7603 -14.7326 0.0 1 -14.7326 6

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 S 2,728 $82.63 d 143,230 direct yes -0.7603 -14.7326 0.0 1 -14.7326 6

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 M 21,000 $18.30 a 152,032 direct -0.7603 -14.7326 0.0 1 -14.7326 6

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 S 3,233 $82.76 d 135,333 direct yes -0.7603 -14.7326 0.0 1 -14.7326 6

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 M 33,000 $13.88 a 148,842 direct -0.7603 -14.7326 0.0 1 -14.7326 6

LEONARD JOHN M - Director - Officer PRESIDENT AND CEO

2021-04-02 20:46:42 -0400 2021-04-01 S 13,895 $83.00 d 693,368 direct yes -0.7603 -14.7326 0.0 1 -14.7326 6

LEONARD JOHN M - Director - Officer PRESIDENT AND CEO

2021-04-02 20:46:42 -0400 2021-04-01 M 45,000 $14.58 a 705,536 direct -0.7603 -14.7326 0.0 1 -14.7326 6

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 M 21,000 d 29,090 direct

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 S 1,213 $84.73 d 162,512 direct yes -0.7603 -14.7326 0.0 1 -14.7326 6

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 S 6,768 $81.87 d 169,344 direct yes -0.7603 -14.7326 0.0 1 -14.7326 6

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 S 123 $85.14 d 145,076 direct yes -0.7603 -14.7326 0.0 1 -14.7326 6

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 S 2,644 $81.95 d 147,199 direct yes -0.7603 -14.7326 0.0 1 -14.7326 6

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 S 963 $84.87 d 140,543 direct yes -0.7603 -14.7326 0.0 1 -14.7326 6

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 S 4,818 $81.83 d 145,958 direct yes -0.7603 -14.7326 0.0 1 -14.7326 6

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 S 1,067 $84.94 d 131,032 direct yes -0.7603 -14.7326 0.0 1 -14.7326 6

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 S 8,266 $81.89 d 138,566 direct yes -0.7603 -14.7326 0.0 1 -14.7326 6

LEONARD JOHN M - Director - Officer PRESIDENT AND CEO

2021-04-02 20:46:42 -0400 2021-04-01 M 26,041 d 273,959 direct

LEONARD JOHN M - Director - Officer PRESIDENT AND CEO

2021-04-02 20:46:42 -0400 2021-04-01 M 26,041 $13.40 a 707,263 direct -0.7603 -14.7326 0.0 1 -14.7326 6

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 M 33,001 d 6,116 direct

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 M 33,000 d 39,000 direct

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-04-02 20:42:02 -0400 2021-04-01 S 2,258 $83.85 d 163,725 direct yes -0.7603 -14.7326 0.0 1 -14.7326 6

SEPP-LORENZINO LAURA - Officer EVP, CHIEF SCIENTIFIC OFFICER

2021-03-05 17:54:03 -0500 2021-03-03 A 84,000 a 84,000 direct

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-03-05 17:52:06 -0500 2021-03-03 A 12,250 a 12,250 direct

LEONARD JOHN M - Director - Officer PRESIDENT AND CEO

2021-03-05 17:50:45 -0500 2021-03-03 A 188,363 a 188,363 direct

LEBWOHL DAVID - Officer EVP, CHIEF MEDICAL OFFICER

2021-03-05 17:49:55 -0500 2021-03-03 A 12,750 a 12,750 direct

SCHIERMEIER ANDREW - Officer EVP, CHIEF OPERATING OFFICER

2021-03-05 17:53:15 -0500 2021-03-03 A 13,125 a 13,125 direct

RIVERA JOSE E - Officer EVP, GENERAL COUNSEL

2021-03-05 17:52:06 -0500 2021-03-03 A 73,500 a 73,500 direct

GODDARD GLENN - Officer EVP, CHIEF FINANCIAL OFFICER

2021-03-05 17:49:05 -0500 2021-03-03 A 12,250 a 12,250 direct

LEBWOHL DAVID - Officer EVP, CHIEF MEDICAL OFFICER

2021-03-05 17:49:55 -0500 2021-03-03 A 76,500 a 76,500 direct

SEPP-LORENZINO LAURA - Officer EVP, CHIEF SCIENTIFIC OFFICER

2021-03-05 17:54:03 -0500 2021-03-03 A 14,000 a 14,000 direct

SCHIERMEIER ANDREW - Officer EVP, CHIEF OPERATING OFFICER

2021-03-05 17:53:15 -0500 2021-03-03 A 78,750 a 78,750 direct

LEONARD JOHN M - Director - Officer PRESIDENT AND CEO

2021-03-05 17:50:45 -0500 2021-03-03 A 31,394 a 31,394 direct

GODDARD GLENN - Officer EVP, CHIEF FINANCIAL OFFICER

2021-03-05 17:49:05 -0500 2021-03-03 A 73,500 a 73,500 direct

FORMELA JEAN FRANCOIS - Director see footnote

2021-03-01 13:59:47 -0500 2021-02-26 S 501,945 $60.29 d 1,113,376 indirect -3.2172 -27.2372 10.5576 25.3397 23 -27.2372 6

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
INTELLIA THERAPEUTICS INC NTLA 2021-04-14 22:15:03 UTC -0.1931 0.2531 1700000
INTELLIA THERAPEUTICS INC NTLA 2021-04-14 21:45:03 UTC -0.1931 0.2531 1700000
INTELLIA THERAPEUTICS INC NTLA 2021-04-14 21:15:03 UTC -0.1931 0.2531 1700000
INTELLIA THERAPEUTICS INC NTLA 2021-04-14 20:45:03 UTC -0.1931 0.2531 1700000
INTELLIA THERAPEUTICS INC NTLA 2021-04-14 20:15:04 UTC -0.1931 0.2531 1700000
INTELLIA THERAPEUTICS INC NTLA 2021-04-14 19:45:03 UTC -0.1931 0.2531 1700000
INTELLIA THERAPEUTICS INC NTLA 2021-04-14 19:15:03 UTC -0.1931 0.2531 1700000
INTELLIA THERAPEUTICS INC NTLA 2021-04-14 18:45:02 UTC -0.1902 0.2502 1700000
INTELLIA THERAPEUTICS INC NTLA 2021-04-14 18:15:03 UTC -0.1902 0.2502 1700000
INTELLIA THERAPEUTICS INC NTLA 2021-04-14 17:45:03 UTC -0.1902 0.2502 1700000
INTELLIA THERAPEUTICS INC NTLA 2021-04-14 17:15:03 UTC -0.1902 0.2502 1700000
INTELLIA THERAPEUTICS INC NTLA 2021-04-14 16:45:03 UTC -0.19 0.25 1700000
INTELLIA THERAPEUTICS INC NTLA 2021-04-14 16:15:03 UTC -0.19 0.25 1700000
INTELLIA THERAPEUTICS INC NTLA 2021-04-14 15:45:03 UTC -0.19 0.25 1700000
INTELLIA THERAPEUTICS INC NTLA 2021-04-14 15:15:03 UTC -0.19 0.25 1700000
INTELLIA THERAPEUTICS INC NTLA 2021-04-14 14:45:02 UTC -0.2334 0.2934 1700000
INTELLIA THERAPEUTICS INC NTLA 2021-04-14 14:15:03 UTC -0.2334 0.2934 1700000
INTELLIA THERAPEUTICS INC NTLA 2021-04-14 13:45:03 UTC -0.2334 0.2934 1700000
INTELLIA THERAPEUTICS INC NTLA 2021-04-14 13:15:03 UTC -0.2334 0.2934 1700000
INTELLIA THERAPEUTICS INC NTLA 2021-04-14 12:45:03 UTC -0.2334 0.2934 1700000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments